The degree of correction between the expression level of RAB31 and gene expression profiles suggestive of immune infiltration were weak to strong (r = 0.128–0.452) in breast and lung cancers, and strong to very strong (r = 0.38–0.70) in colorectal, liver, stomach, and prostate cancers. The gene discussed is RAB31; the disease is prostate cancer.